Literature DB >> 31263973

Obsessive-Compulsive Symptoms in Schizophrenia: an Up-To-Date Review of Literature.

Chloé Tezenas du Montcel1,2,3, Antoine Pelissolo1,2,3,4, Franck Schürhoff1,2,3,4, Baptiste Pignon5,6,7,8.   

Abstract

PURPOSE OF REVIEW: This review will aim to summarize the current body of epidemiological, clinical and therapeutic knowledge concerning specific co-occurrence of obsessive-compulsive symptoms (OCSs) and schizophrenia spectrum disorder. RECENT
FINDINGS: Almost 30% of the patients with schizophrenia display OCS, and three main contexts of emergence are identified: prodromal symptoms of schizophrenia, co-occurrence of OCS and schizophrenia and antipsychotics-induced OCS. Recent clinical studies show that patients with SZ and OCS have more severe psychotic and depressive symptoms, higher suicidality and lower social functioning. A recent cognitive investigation found that OCS and delusions share specific metacognitive profiles, particularly through a heightened need to control thoughts. Finally, a recent cross-sectional study of clozapine-induced OCS found a dose-response relationship between clozapine and OCS. OCS appeared reliably as linked to poorer outcomes among patients with schizophrenia. However, the specific clinical value of OCS among other prodromal symptoms of schizophrenia remains unknown.

Entities:  

Keywords:  Antipsychotics; Obsessive-compulsive disorder; Obsessive-compulsive symptoms; Schizo-obsessive disorder; Schizophrenia; Ultra-high risk (UHR) of psychosis

Year:  2019        PMID: 31263973     DOI: 10.1007/s11920-019-1051-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  73 in total

1.  Reliability and validity of a depression rating scale for schizophrenics.

Authors:  D Addington; J Addington; E Maticka-Tyndale; J Joyce
Journal:  Schizophr Res       Date:  1992-03       Impact factor: 4.939

2.  Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs.

Authors:  R Ramasubbu; A Ravindran; Y Lapierre
Journal:  Pharmacopsychiatry       Date:  2000-11       Impact factor: 5.788

3.  Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders.

Authors:  L de Haan; D H Linszen; R Gorsira
Journal:  J Clin Psychiatry       Date:  1999-06       Impact factor: 4.384

Review 4.  Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment.

Authors:  Michael Poyurovsky; Abraham Weizman; Ronit Weizman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.

Authors:  Stephen R Marder; Wayne Fenton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

Review 6.  Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia?

Authors:  Alexandra Bottas; Robert G Cooke; Margaret A Richter
Journal:  J Psychiatry Neurosci       Date:  2005-05       Impact factor: 6.186

7.  The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence.

Authors:  Damiaan Denys; Joseph Zohar; Herman G M Westenberg
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

8.  [Prodromal symptoms of schizophrenics syndrome in children and adolescent].

Authors:  Izabela Łucka; Monika Fryze; Aleksandra Cebella; Ewa Staszewska
Journal:  Psychiatr Pol       Date:  2002 Nov-Dec       Impact factor: 1.657

Review 9.  Evidence-based pharmacotherapy of obsessive-compulsive disorder.

Authors:  Naomi A Fineberg; Tim M Gale
Journal:  Int J Neuropsychopharmacol       Date:  2004-09-28       Impact factor: 5.176

10.  Emergence of obsessive compulsive symptoms during treatment with clozapine.

Authors:  R W Baker; K N Chengappa; J W Baird; S Steingard; M A Christ; N R Schooler
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

View more
  4 in total

Review 1.  [Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment].

Authors:  Frederike Schirmbeck; Mathias Zink
Journal:  Nervenarzt       Date:  2022-07-05       Impact factor: 1.297

2.  The Relationships Between Obsessive-Compulsive Disorder and Psychosis: An Unresolved Issue.

Authors:  Stefania Palermo; Donatella Marazziti; Stefano Baroni; Filippo Maria Barberi; Federico Mucci
Journal:  Clin Neuropsychiatry       Date:  2020-06

Review 3.  Recognizing Psychosis in Autism Spectrum Disorder.

Authors:  Michele Ribolsi; Federico Fiori Nastro; Martina Pelle; Caterina Medici; Silvia Sacchetto; Giulia Lisi; Assia Riccioni; Martina Siracusano; Luigi Mazzone; Giorgio Di Lorenzo
Journal:  Front Psychiatry       Date:  2022-02-28       Impact factor: 4.157

4.  Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness.

Authors:  Ulrika Hylén; Aidan McGlinchey; Matej Orešič; Susanne Bejerot; Mats B Humble; Eva Särndahl; Tuulia Hyötyläinen; Daniel Eklund
Journal:  Front Psychiatry       Date:  2021-11-26       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.